Ovid Therapeutics Inc (OVID) support and resistance · rev $733.0K
Ovid Therapeutics Inc (OVID) is a biotechnology company listed on US.
This page maps Ovid Therapeutics Inc (OVID) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported OVID revenue for 2026-06-30 was $733.0K. Net income was -$32.0M. OVID currently screens at market cap $23.5M.
OVID currently screens at market cap $23.5M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new OVID 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the OVID quote page for the session range and the stock page for the full model.
Not investment advice.